Miromatrix

Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award

  (Eden Prairie, MN) —  July 13, 2023 — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that its poster entitled Initial Preclinical Evaluation of a Bioengineered Kidney was selected Best in Congress at the recent American Transplant Congress (ATC). “We appreciate the opportunity to present our kidney work at ATC, and

Miromatrix

  (Eden Prairie, MN) — Sept. 20, 2022  — Miromatrix Medical Inc.  a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced CEO Jeff Ross will present at the Bioregate European Regenerative Medicine Forum. The conference, held this year on September 21-23 in Louvain-la-Neuve, Belgium, is dedicated to the 4R Medicine, Repair, Replacement, Regeneration, and Reprogramming. Mr. Ross will